免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

臨床試驗

TxAccess and Dd-cfDNA for Improved Care of Patients With Delayed Graft Function

NCT:NCT07825688 · NOT_YET_RECRUITING

NCT IDNCT07825688
狀態NOT_YET_RECRUITING
開始日期2026-09-15
完成時間2029-06-30
SponsorDuke University (OTHER)
First posted
Last updated

簡要摘要

This is a prospective multicenter nonrandomized pragmatic hybrid effectiveness-implementation study to test the effectiveness of TxAccess in improving time to renal recovery and immunologic outcomes in patients with delayed graft function (DGF) and to assess barriers and facilitators to implementation of TxAccess in the post-transplant care period. Research blood will be collected for donor-derived cell-free DNA testing, and patient questionnaires will be administered.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。

↑